Literature DB >> 6124385

The metabolism and elimination of S-carboxymethyl-L-cysteine in man.

R H Waring, S C Mitchell.   

Abstract

The metabolism of 14C- and 35S-labeled S-carboxymethylcysteine (SCMC) has been compared. The majority of the dose appeared in urine in the first 24 hr; no activity was detectable in feces. Use of 25S-labeled compound gave small amounts of inorganic 35S-sulfate, whereas 14C-labeled material was degraded to give some [14C]urea. Peak excretion of the parent compound occurred first after administration of SCMC; metabolites requiring one chemical modification for their formation were maximally excreted 1-4 hr after the dose and those involving more metabolic processes appeared later (4-8 hr).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124385

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  S-CMC-Lys-dependent stimulation of electrogenic glutathione secretion by human respiratory epithelium.

Authors:  F Guizzardi; S Rodighiero; A Binelli; S Saino; E Bononi; S Dossena; M L Garavaglia; C Bazzini; G Bottà; M Conese; L Daffonchio; R Novellini; M Paulmichl; G Meyer
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

2.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 3.  Role of reactive metabolites in the circulation in extrahepatic toxicity.

Authors:  Roy M Irving; Adnan A Elfarra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-06-11       Impact factor: 4.481

4.  An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.

Authors:  E F Karim; J S Millership; D J Temple; A D Woolfson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

Review 5.  Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action.

Authors:  Elisabetta Pace; Isa Cerveri; Donato Lacedonia; Gregorino Paone; Alessandro Sanduzzi Zamparelli; Rossella Sorbo; Marcello Allegretti; Luigi Lanata; Francesco Scaglione
Journal:  Pharmaceutics       Date:  2022-06-14       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.